2016 Grant Program

whitePaper | December 15, 2022

Every segment in health care is experiencing extraordinary changes in the workforce. Burnout, turnover, rising labor costs and skill gaps are diminishing the supply of qualified workers.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | November 24, 2022

The 2015 ICER Policy Summit convened an influential group of evidence policy leaders from insurers, pharmacy benefit management firms.

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern. Until recently, researchers were limited by the lack of a specific ICD-10 diagnosis code for post-COVID conditions.

whitePaper | November 8, 2022

This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings.

whitePaper | January 14, 2022

In the past year, more than nine billion doses of coronavirus vaccines have been administered, in at least 197 countries worldwide according to the BBC and Oxford University.